X0306 4 2021-12-31 0 0001823239 MARAVAI LIFESCIENCES HOLDINGS, INC. MRVI 0001827977 GTCR INVESTMENT XI LLC C/O GTCR, LLC 300 N. LASALLE SUITE 5600 CHICAGO IL 60654 1 0 1 0 0001833157 MARAVAI LIFE SCIENCES HOLDINGS, LLC C/O MARAVAI LIFE SCIENCES HOLDINGS, INC. 10770 WATERIDGE CIRCLE SUITE 200 SAN DIEGO CA 92121 1 0 1 0 0001832794 MARAVAI LIFE SCIENCES HOLDINGS 2, LLC C/O MARAVAI LIFE SCIENCES HOLDINGS, INC. 10770 WATERIDGE CIRCLE SUITE 200 SAN DIEGO CA 92121 1 0 1 0 0001591435 GTCR FUND XI/B LP C/O GTCR, LLC 300 N. LASALLE SUITE 5600 CHICAGO IL 60654 1 0 1 0 0001591436 GTCR FUND XI/C LP C/O GTCR, LLC 300 N. LASALLE SUITE 5600 CHICAGO IL 60654 1 0 1 0 0001591432 GTCR CO-INVEST XI LP C/O GTCR, LLC 300 N. LASALLE SUITE 5600 CHICAGO IL 60654 1 0 1 0 0001828028 GTCR PARTNERS XI/A&C LP C/O GTCR, LLC 300 N. LASALLE SUITE 5600 CHICAGO IL 60654 1 0 1 0 0001827959 GTCR PARTNERS XI/B LP C/O GTCR, LLC 300 N. LASALLE SUITE 5600 CHICAGO IL 60654 1 0 1 0 Class A Common Stock 21681033 I See footnotes Class B Common Stock 2021-12-31 4 D 0 2570415 0.00 D 123669196 I See footnotes Common Units 2021-12-31 4 D 0 2570415 0.00 D Class A Common Stock 2570415 123669196 I See footnotes Reflects shares of Class A Common Stock, par value $0.01 per share (the "Class A Common Stock"), of Maravai LifeSciences Holdings, Inc. (the "Issuer") held directly by Maravai Life Sciences Holdings 2, LLC ("MLSH 2"). MLSH 2 is managed by a board of managers controlled by GTCR XI/C LP ("GTCR Fund XI/C"). GTCR Partners XI/A&C LP ("GTCR Partners XI/A&C") is the general partner of GTCR Fund XI/C. GTCR Investment XI LLC ("GTCR Investment XI") is the general partner of GTCR Partners XI/A&C. GTCR Investment XI is managed by a board of managers (the "GTCR Board of Managers") consisting of Mark M. Anderson, Craig A. Bondy, Aaron D. Cohen, Sean L. Cunningham, Benjamin J. Daverman, David A. Donmini, Constantine S. Mihas and Collin E. Roche, and no single person has voting or dispositive authority over the Class A Common Stock. (Continued From Footnote 1) Each of GTCR Partners XI/A&C, GTCR Investment XI and the GTCR Board of Managers may be deemed to share beneficial ownership of the Class A Common Stock held of record by MLSH 2, and each of the individual members of the GTCR Board of Managers disclaims beneficial ownership of the Class A Common Stock held of record by MLSH 2 except to the extent of his pecuniary interest therein. Reflects shares of the Issuer's Class B Common Stock, par value $0.01 per share (the "Class B Common Stock"), held directly by Maravai Life Sciences Holdings, LLC ("MLSH 1"). MLSH 1 is managed by a board of managers controlled by GTCR Fund XI/B LP ("GTCR Fund XI/B") and GTCR Co-Invest XI LP ("GTCR Co-Invest XI"). GTCR Partners XI/B LP ("GTCR Partners XI/B") is the general partner of GTCR Fund XI/B. GTCR Investment XI is the general partner of GTCR Co-Invest XI and GTCR Partners XI/B. GTCR Investment XI is managed by the GTCR Board of Managers, and no single person has voting or dispositive authority over the Class B Common Stock. (Continued From Footnote 3) Each of GTCR Partners XI/B, GTCR Investment XI and the GTCR Board of Managers may be deemed to share beneficial ownership of the Class B Common Stock held of record by MLSH 1, and each of the individual members of the GTCR Board of Managers disclaims beneficial ownership of the Class B Common Stock held of record by MLSH 1 except to the extent of the pecuniary interest therein. Pursuant to the Exchange Agreement dated November 19, 2020, by and among the Issuer Maravai Topco Holdings, LLC and MLSH 1 (the "Exchange Agreement"), the Common Units (together with one share of Class B Common Stock for every Common Unit) are exchangeable for one share of the Issuer's Class A common stock, par value $0.01 per share (the "Class A Common Stock"). Common Units do not expire. Reflects Common Units owned directly by MLSH 1. Each Common Unit is exchangeable for one share of Class A Common Stock pursuant to the Exchange Agreement. Each of the reporting persons is a director-by-deputization solely for purposes of Section 16 of the Securities Exchange Act of 1934. /s/ Carl Hull, as chief executive officer of Maravai Life Sciences Holdings, LLC 2022-01-04 /s/ Carl Hull, as chief executive officer of Maravai Life Sciences Holdings 2, LLC 2022-01-04 /s/ Jeffrey Wright, by power of attorney for GTCR Fund XI/B LP 2022-01-04 /s/ Jeffrey Wright, by power of attorney for GTCR Fund XI/C LP 2022-01-04 /s/ Jeffrey Wright, by power of attorney for GTCR Co-Invest XI LP 2022-01-04 /s/ Jeffrey Wright, by power of attorney for GTCR Partners XI/A&C LP 2022-01-04 /s/ Jeffrey Wright, by power of attorney for GTCR Partners XI/B LP 2022-01-04 /s/ Jeffrey Wright, by power of attorney for GTCR Investment XI LLC 2022-01-04